StockIQ.techPerspective Therapeutics, Inc. (CATX) Stock Analysis
Free AI-powered analysis and research for Perspective Therapeutics, Inc. stock
Sector: Healthcare
Full CATX report
Perspective Therapeutics, Inc. (CATX) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze CATX Now →📰 Latest Update
Perspective Therapeutics (CATX) Stock Sees Fair Value Moves Lower As Analysts Weigh Lead 212 Risks
Sun, November 1, 2026 at 2:12 AM UTC 4 min read
Perspective Therapeutics (CATX) has seen its Fair Value estimate reduced from US$12.29 to US$10.57 per share, reflecting a cautious outlook on its lead-212 platform amid execution and timeline uncertainties. Analysts from BMO Capital initiated coverage with an Outperform rating and a US$11 target, while Piper Sandler and BofA lowered their targets, highlighting ongoing regulatory discussions and execution risks. The article emphasizes the evolving narrative around the company’s clinical progress and financial forecasts.